VIENNA, Jan. 10, 2020 /PRNewswire/ -- The massive output of modern short-read next generation sequencing (NGS) platforms allows to multiplex hundreds of samples to be processed in one NGS run. Each ...
VIENNA, Nov. 25, 2025 /PRNewswire/ -- Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale data generation ...
VIENNA, Oct. 16, 2025 /PRNewswire/ -- Lexogen, a leader in RNA sequencing technologies, announces the launch of the miRVEL Profiling Small RNA-Seq Library Prep Kit, designed to facilitate small RNA ...
VIENNA, April 10, 2024 /PRNewswire/ --Lexogen, a biotech company dedicated to advancing RNA research with innovative RNA-Seq products, is pleased to introduce solutions specifically optimized for ...
ZÜRICH and VIENNA, Oct. 15, 2024 /PRNewswire/ -- Cytosurge AG, a leader in single-cell manipulation, and Lexogen, a pioneer in RNA sequencing solutions, have announced their partnership to advance ...
VIENNA, Nov. 8, 2023 /PRNewswire/ -- Lexogen is proud to be featured in Nature Methods with a Technical Application Note in the November edition of this esteemed journal. In this groundbreaking ...
VIENNA, Sept. 1, 2022 /PRNewswire/ -- Lexogen, a transcriptomics and Next-Generation Sequencing company announced the release of the new RiboCop rRNA Depletion Kit for Yeast today. Total RNA is ...
VIENNA, Nov. 14, 2023 /PRNewswire/ -- Lexogen, a pioneer in the field of genomics and transcriptomics, is proud to introduce the groundbreaking LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit, a ...
Lexogen, a leader in RNA sequencing technologies, is thrilled to announce the launch of the RiboCop rRNA Depletion Kit for Fish, a dedicated solution to facilitate transcriptome analysis of fish ...
Cytosurge AG, a leader in single-cell manipulation, and Lexogen, a pioneer in RNA sequencing solutions, have announced their partnership to advance live-cell sequencing (Live-seq). The collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results